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The authors of this article [1] have to be congratulated for their
clear presentation of stepwise, process-based informed con-
sent, including evidence-based justification, full patient infor-
mation on benefits and risks, and interactive communication
with enough time for the patient before taking the decision on
whether to undergo an examination. Recchia et al. are in line
with the clinical consent process [2], and even some radiolog-
ical articles head in the same direction [3, 4]. The authors will
likely get unanimous approval for their approach whenever
risky interventions or complex examinations with an elevated
dose level are considered. Non-invasive imaging examina-
tions using low-dose levels, however, are not discussed dif-
ferently by the authors, although this contrasts to the reality in
radiology departments in Europe, the USA [5] and probably
most countries. In other words, the theory is not applied in a
large segment of the real world, and this brings up several
questions:
Who is responsible for obtaining informed consent?
Recchia et al. do not specify this point; they seem to rely on a
model where the physician—as a general practitioner—has
repeated contacts to the patient, allowing for an ongoing
interaction and a chronological separation of the different
steps. Most diagnostic radiologists performing radiography,
fluoroscopy and CT see their patients just once, for the exam-
ination. To achieve a correct informed consent procedure, they
either have to offer an additional previous consultation or to
share the task with another medical professional, such as the
referring physician [6]. Correct justification and full informa-
tion of the patient in the latter scenario are the primary respon-
sibility of the referrer whereas the radiologist acts on demand
in the first phase and has the main responsibility in giving
answers to questions of the patient, in verifying that the patient
has understood the information and in documenting the con-
sent.Whatever the solution, the changes in practice will have a
substantial impact on the operational load in an imaging
department [6]. This may be the reason for US academic
departments to delegate the duty of obtaining informed con-
sent to radiological technologists [5], a solution that probably
cannot fully satisfy all needs. In any case, both the referrer, the
radiologist and any medical professional involved need ade-
quate education and training in this task. The new guidance
document of the European Union for training and education in
medical radiation protection, as currently developed in the EC
MEDRAPET project, will cover this in detail (www.
medrapet.eu).
Is informed consent identical for all imaging examinations
using ionising radiation?
In their clear, interactive approach, Recchia et al. do not
differentiate between paediatric whole-body PET-CT and
two-plane radiography of a broken finger in an elderly
patient. Indeed, the risk of cancer induction may differ by
a factor well above 1,000 between these two examples,
and it seems logical that our efforts concentrate on those
exposure situations with a significant risk. The wide-
spread lack of qualified professional staff and economic
constraints of the healthcare systems, due to the financial
crisis, underline this point. Thus, we might postulate an
approach adapted to the cancer risk, i.e. based on organ
doses, the age at exposure and gender. This would mean a
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careful, stepwise process including the parents in the case
of children and an abbreviated procedure in the case of
elderly patients. Furthermore, imaging in emergency situ-
ations has to respect the medical urgency, and situations
where the patient is not able to give an informed consent
require a modified approach, e.g. after loss of
consciousness.
Is there a threshold for the need for risk information?
Recchia et al. briefly mention authors discussing a minimal
effective dose of 1 mSv for detailed risk information [6]. To
control the workload in a busy department, this might be an
attractive pragmatic option: most radiographic examinations
would pass below this threshold, and even modern low-dose
CT protocols might fit, whereas most CT, fluoroscopic and
interventional examinations would deserve the full process-
based steps for getting informed consent. For higher dose
investigations, e.g. those above 10 mSv, Malone et al. suggest
a more detailed informed consent procedure and forms spe-
cific for the examination [6].
Scientific arguments would even favour a risk-based rather
than dose-based threshold, e.g. to allow for different decisions
for a baby girl and an adult, according to the BEIR VII data
[7]. When patient groups were asked about the information
they wanted to receive prior to a medical act with potentially
severe side effects, Barnett et al. [8] reported a 0.1 % risk to be
critical for many; subjective needs for information varied
widely and were greater in young than elderly people. Terry
mentions that there is no formally recognised threshold of risk
above which we ought to obtain informed consent but that an
ethical guideline might be any risk greater than that which we
might ordinarily encounter when carrying out normal daily
activities [2]. This would correspond roughly to a risk of
1:2,000.
How do we communicate the risk and stochastic
uncertainties?
In a survey of physicians affiliated with tertiary hospitals,
Karsli et al. [4] obtained the best support for the following
two statements: (1) that X-rays are a known human carcinogen
and that there is an epidemiological association between X
rays and cancer; (2) that the risk of cancer from radiation
exposure from a CT scan is much smaller than the high
background risk of cancer in the population. Recchia et al.
[1] are right in suggesting a combination of visual displays
and descriptions of the risk in order to help the patient under-
stand the magnitude. It may be easier to perceive the approx-
imate exposure of a specific examination if the dose is
expressed by the corresponding number of chest radiographs
rather than by the physical dose. Similarly, patients are more
likely to get an idea of the risk when this is expressed as “one
patient out of x patients” rather than a percent number.
Regarding stochastic risk uncertainties, Recchia et al. clearly
state that “patients must be fully informed of what is known
and what is unknown”. This task is not as easy as they claim
and rather time-consuming: while the mean risk to the popu-
lation by a certain examination can usually be quantified, the
individual risk of cancer induction depends on many factors,
such as organ dose, sex and age; recent research has even
shown that there is an important genetic variation in the
sensitivity to ionising radiation. Thus, even if we fully accept
the linear no-threshold (LNT) model, it is not easy for experts
and difficult for patients to understand the absolute risk to an
individual person with its large statistical uncertainty. It may
be preferable to justify that the benefits to the patient are well
above the range of the risk and that the clinical question
cannot be answered by an alternative diagnostic procedure.
Arguing with these uncertainties and the difficulty of exactly
defining the individual age- and gender-specific risk of an
imaging examination, Image Gently and Image Wisely
(www.imagegently.org; www.imagewisely.org) do not
support a formal informed consent for diagnostic ionising
radiation. The two campaigns for pragmatic radiation
protection in the US advocate for providing every patient
with educational material and for replacing informed consent
by a standardised “radiation consent” form, similar to the form
used before the injection of contrast media.
In conclusion, there are no easy answers to these questions
that do not provoke debates. We need to improve informed
consent for radiation exposure in imaging. In times of limited
resources, concentrating on critical situations and adapting the
process to the magnitude of the risk deserve consideration and
might have a stronger impact on the practice of imaging than
asking for a rigid full process.
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